Health

Gyros Protein Technologies and Biotage collaborate on innovative automated solution to enhance peptide purification efficiency

Gyros Protein Technologies AB and Biotage have joined forces to offer Biotage® PeptiPEC, a high-throughput peptide purification system, on Biotage® Extrahera™ automated sample preparation system. The new partnership aims to provide a fast and environmentally sustainable solution for high-throughput peptide purification.

Leveraging Gyros Protein Technologies’ proprietary PEC catch and release technology, the Biotage PeptiPEC high-throughput kits allow for automation in a plate-based format, enabling scientists to advance drug discovery processes. The PEC technology combined with Biotage Extrahera can purify up to 96 peptides in parallel, offering significant time savings and lower solvent consumption compared to the traditional sequential HPLC method.

The automated plate-based peptide purification workflow addresses the challenges posed by the generation of crude peptide samples at a rate that exceeds the capacity of HPLC. The new workflow allows scientists to conduct screening and development processes using purified peptides, leading to more robust and accurate results.

Those interested in learning more about Biotage PeptiPEC can sign up to receive information about the product launch by visiting the following webpage: https://www.biotage.com/gyros-partnership. This plate-based automated solution for parallel high-throughput peptide purification aims to remove bottlenecks for peptide scientists and provide a complete workflow solution from synthesis to evaporation.

Tomas Blomquist, CEO of Biotage, expressed excitement about the partnership, stating that it strengthens the company’s position in the rapidly growing peptide market. This collaboration is in line with Biotage’s mission to provide high-quality, end-to-end separation and sample preparation solutions to scientists worldwide. Similarly, Mark Vossenaar, Vice President and General Manager of the Biopharmaceutical Development Division at Mesa Labs, emphasized that the partnership with Biotage is a step further in the commitment to provide state-of-the-art peptide solutions across the entire value chain, from research to large-scale production.

Overall, the partnership between Gyros Protein Technologies and Biotage aims to equip researchers with faster and more sustainable processes to advance drug discovery and support the needs of scientists in the peptide market.

Emily Thompson

Dr. Emily Thompson is a highly respected medical professional and seasoned health journalist, contributing her expertise to our news website. With a medical degree from Johns Hopkins University School of Medicine and over 15 years of experience in clinical practice, Dr. Thompson possesses a deep understanding of various health issues.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker